Correlation Engine 2.0
Clear Search sequence regions


  • antibodies (1)
  • antigen (1)
  • genomes (1)
  • humans (1)
  • klebsiella (4)
  • o antigen (7)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    Klebsiella pneumoniae is one of the priority objects for the development of new therapies against infections. The species has been perceived as of limited variety of O antigens (11 O serotypes identified to date). That trait makes lipopolysaccharide an attractive target for protective antibodies. Nowadays, K. pneumoniae O antigens encoding genes are often analysed by bioinformatic tools, such as Kaptive, indicating higher actual diversity of the O antigen loci. One of the novel K. pneumoniae O loci for which the antigen structure has not been elucidated so far is OL101. In this study, four clinical isolates predicted as OL101 were characterized and found to have the O antigen structure composed of β-Kdop-[→3)-α-l-Rhap-(1→4)-α-d-Glcp-(1→]n, representing a novel serotype O13. Identification of the β-Kdop terminus was based on the analysis of the complete LPS molecule by the HR-MAS NMR spectroscopy. The bioinformatic analysis of 71,377 K. pneumoniae genomes from public databases (July 2023) revealed a notable OL101 prevalence of 6.55 %. Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

    Citation

    Daria Artyszuk, Wojciech Jachymek, Radosław Izdebski, Marek Gniadkowski, Jolanta Lukasiewicz. The OL101 O antigen locus specifies a novel Klebsiella pneumoniae serotype O13 structure. Carbohydrate polymers. 2024 Feb 15;326:121581

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38142087

    View Full Text